Versant Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,149
| Closed | -$310K | – | 2640 |
|
|
2025
Q2 | $310K | Buy |
3,149
+371
| +13% | +$35.1K | 0.05% | 307 |
|
|
2025
Q1 | $257K | Buy |
2,778
+2,328
| +517% | +$215K | 0.04% | 337 |
|
|
2024
Q4 | $40.9K | Buy |
450
+183
| +69% | +$16.8K | 0.01% | 668 |
|
|
2024
Q3 | $25.8K | Buy |
267
+219
| +456% | +$21.4K | 0.01% | 716 |
|
|
2024
Q2 | $4.41K | Buy |
48
+25
| +109% | +$2.32K | ﹤0.01% | 1261 |
|
|
2024
Q1 | $2.12K | Buy |
23
+2
| +10% | +$187 | ﹤0.01% | 1327 |
|
|
2023
Q4 | $2K | Hold |
21
| – | – | ﹤0.01% | 1284 |
|
|
2023
Q3 | $1.96K | Hold |
21
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q2 | $1.92K | Buy |
21
+7
| +50% | +$574 | ﹤0.01% | 1383 |
|
|
2023
Q1 | $1.03K | Hold |
14
| – | – | ﹤0.01% | 1434 |
|
|
2022
Q4 | $1.17K | Hold |
14
| – | – | ﹤0.01% | 1264 |
|
|
2022
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1194 |
|
|
2022
Q1 | $2K | Hold |
14
| – | – | ﹤0.01% | 1099 |
|
|
2021
Q4 | $2K | Hold |
14
| – | – | ﹤0.01% | 1096 |
|
|
2021
Q3 | $2K | Hold |
14
| – | – | ﹤0.01% | 1095 |
|
|
2021
Q2 | $3K | Hold |
14
| – | – | ﹤0.01% | 1017 |
|
|
2021
Q1 | $4K | Hold |
14
| – | – | ﹤0.01% | 1070 |
|
|
2020
Q4 | $4K | Hold |
14
| – | – | ﹤0.01% | 947 |
|
|
2020
Q3 | $3K | Hold |
14
| – | – | ﹤0.01% | 952 |
|
|
2020
Q2 | $2K | Sell |
14
-10
| -42% | -$1.86K | ﹤0.01% | 1030 |
|
|
2020
Q1 | $4K | Sell |
24
-5
| -17% | -$890 | ﹤0.01% | 810 |
|
|
2019
Q4 | $4K | Hold |
29
| – | – | ﹤0.01% | 972 |
|
|
2019
Q3 | $3K | Sell |
29
-8
| -22% | -$1.04K | ﹤0.01% | 1067 |
|
|
2019
Q2 | $4K | Sell |
37
-129
| -78% | -$15.3K | ﹤0.01% | 998 |
|
|
2019
Q1 | $20K | Sell |
166
-379
| -70% | -$47.6K | 0.01% | 605 |
|
|
2018
Q4 | $63K | Sell |
545
-25
| -4% | -$2.95K | 0.03% | 196 |
|
|
2018
Q3 | $71K | Sell |
570
-78
| -12% | -$8.61K | 0.03% | 203 |
|
|
2018
Q2 | $55K | Sell |
648
-9
| -1% | -$661 | 0.02% | 271 |
|
|
2018
Q1 | $39K | Sell |
657
-25
| -4% | -$1.42K | 0.02% | 370 |
|
|
2017
Q4 | $35K | Sell |
682
-20
| -3% | -$1.05K | 0.01% | 421 |
|
|
2017
Q3 | $39K | Sell |
702
-41
| -6% | -$2.17K | 0.02% | 332 |
|
|
2017
Q2 | $46K | Buy |
743
+225
| +43% | +$13.1K | 0.03% | 272 |
|
|
2017
Q1 | $26K | Buy |
518
+81
| +19% | +$3.86K | 0.01% | 485 |
|
|
2016
Q4 | $18K | Hold |
437
| – | – | 0.01% | 621 |
|
|
2016
Q3 | $20K | Buy |
437
+11
| +3% | +$549 | 0.01% | 559 |
|
|
2016
Q2 | $21K | Sell |
426
-11
| -3% | -$555 | 0.01% | 517 |
|
|
2016
Q1 | $21K | Buy |
437
+5
| +1% | +$193 | 0.01% | 493 |
|
|
2015
Q4 | $16K | Buy |
+432
| New | +$17.3K | 0.01% | 574 |
|
Other funds holding AMED
IA
MCI
HNB
Versant Capital Management's AMED Position: Q3 2025 in Review
Versant Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,149 shares — an estimated $310K sold.
Versant Capital Management first reported a position in AMED in Q4 2015 and held it in 39 quarters. The position peaked at $310K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Versant Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Versant Capital Management sold 3,149 Amedisys shares in Q3 2025, an estimated $310K.
- Versant Capital Management first reported a position in Amedisys in Q4 2015 and held it in 39 quarters.
- Versant Capital Management's Amedisys position peaked at $310K in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Versant Capital Management's 13F filing for Q3 2025, filed 27 Oct 2025.